Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome: A Randomized, Double-blinded,Placebo- Controlled Multicenter Study

NCT02614963 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT02614963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02614963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome: A Randomized, Double-blinded,Placebo- Controlled Multicenter Study
Lead sponsor
Shandong University
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2015
Completion date
July 31, 2016
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of clostridium butyricum in treating irritable bowel syndrome